Study Details
Design, interventions, and primary outcomes
About This Study
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Design
Interventions / Regimen
- Other: Questionnaires — The PROFFIT questionnaire is a PRO instrument composed by 16 items encompassing all the major life domains where FT can be expressed and is formed by two type of items: (1) outcome (items 1-7) and (2) determinants (items 8-16). EORTC QLQ-C30, EORTC QLQ-BR42 and HADS questionnaires are currently used in clinical practice
Primary Outcomes
- Financial Toxicity at one year (baseline visit (before surgery or chemotherapy/endocrine therapy depending on the cohort), at the end of chemotherapy/endocrine therapy (if applicable), after surgery, 6 months after surgery, 1 year after the baseline questionnaires)
Phase: Not Applicable
Status: Recruiting
Start Date: 2025-09-30
Completion: 2034-09
Sex: ALL
Volunteers: false
Enrollment: 864 (ESTIMATED)
- Maria Carmela Piccirillo, MD (PRINCIPAL_INVESTIGATOR) - National Cancer Institute, Naples
- Martina Pagliuca, MD (PRINCIPAL_INVESTIGATOR) - Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples
- Other: Questionnaires — The PROFFIT questionnaire is a PRO instrument composed by 16 items encompassing all the major life domains where FT can be expressed and is formed by two type of items: (1) outcome (items 1-7) and (2) determinants (items 8-16). EORTC QLQ-C30, EORTC QLQ-BR42 and HADS questionnaires are currently used in clinical practice